Investigation of the impact of patient satisfaction with subcutaneous injection of Bulevirtide on therapy response in Hepatitis B/D co-infectio
Recruiting
- Conditions
- B17.0Acute delta-(super)infection in chronic hepatitis B
- Registration Number
- DRKS00033153
- Lead Sponsor
- niversitätsklinikum Leipzig
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 114
Inclusion Criteria
age = 18 years
- written informed consent
- HBV/HDV coinfection
- therapy with bulevirtide
- at least three visits during bulevirtide therapy
Exclusion Criteria
- age < 18 years
- missing written informed consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prospective assessment of patient satisfaction
- Secondary Outcome Measures
Name Time Method Correlation with virological and biochemical treatment response